Phenylephrine: EU Manufacturers, Don’t Panic, But May Be Time To Prepare

European OTC manufacturers don't need to worry too much about the questions raised about oral phenylephrine's efficacy as a nasal decongestant in the US, advises industry physician James Walmsley. However, he said it may be an opportunity for companies to “ask themselves how they would respond to any future challenges on their core active ingredients.”